Use of WEGOVY for this indication is supported by a 68-week, double-blind, placebo-controlled clinical trial in 201 pediatric patients aged 12 years and older with a BMI corresponding to 95th percentile for age and sex and from studies in adult patients with obesity [see Clinical Studies (14.3)]
This typically equals around 15% of their body weight when combined with a reduced-calorie diet and regular exercise
The interaction between GLP-1s and birth control is unclear One key problem is that the process by which GLP-1s reduce the effectiveness of birth control isnt well understood
operations at Novo Nordisk, said, Mass compounding of semaglutide is illegal, dangerous, and must stop now, which is why we are doubling down on our commitment to accessibility, availability and affordability of authentic, FDA-approved Wegovy
Retrieved from Smith, S
Members access detailed protocols that go beyond generic charts, including troubleshooting databases, interaction guides, and expert-reviewed dosing recommendations tailored to individual goals
